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Introduction
Epidemiological studies showed that about
one third of the population, particularly the elderly,
experiences dizziness and tinnitus at least once in
their life and about 1-5% develop serious psychoso-
cial complications(1,2).
While tinnitus is defined as an auditory phan-
tom sensations, a “perception of a sound which
result exclusively from activity within the nervous
system without any corresponding mechanical,
vibratory activity within the cochlea”(3), and usually
represents an hearing deficit related phenomena,
dizziness is a pathological dysfunction of the balan-
ce maintenance that is related to unsteadiness, stag-
gering, tendency to fall, etc(3,4).
As stated above, when persistent these disor-
ders may rapidly become a source of serious distur-
bances and handicap at psychological and socio-
professional levels; in fact in 1-3% of the general
population, the tinnitus and dizziness affect the
quality of life, involving sleep disturbance, work
impairment and psychiatric distress(5).
In half of cases this association may find a
possible etiology in the vertebrobasilar insufficien-
cy that could affect either in acute and chronic pre-
sentation; in the first one it could be accompanied
with sudden hearing loss while in the second ones
the 50% of cases suffer from hearing loss(6,7). 
Both acute and chronic clinical manifestations
are lead to failure of microcirculation; in fact the so
known “vertebrobasilar system” is responsible for
Acta Medica Mediterranea, 2012, 28: 291
ABSTRACT
Seventy-eight consecutive subjects, 43 males and 35 females, ranging from 43 to 87 years of age suffering from dizziness
and/or tinnitus due to vertebrobasilar insufficiency without other central nervous system diseases were treated with fixed combination
of cinnarizine and dimenhydrinate two times a day and for two months. 
Data were collected considering the following parameters: age, sex, vestibular symptoms (unsteadiness, staggering, tendency
to fall, swaying, vertigo due to change of position, bowing, walking, eye movements), headache, tinnitus, impaired hearing and aural
fullness. Patients evaluated their vertigo symptoms and/or tinnitus intensities using a graded 3- point visual analog scale ranging from
1 (no symptoms) to 3 (strong symptoms) and their impact of life with classical tinnitus handicap inventory (THI) and dizziness hand-
icap inventory (DHI) at first appointment, during the treatment and after therapy. The results of THI and DHI evidenced a statistical
significant improvement either for tinnitus (t = 3.57; p<0.001) and for vestibular symptoms (t = 4.12; p<0.001); in particular at the
final examination, of the 62 patients suffered from tinnitus, the 38.71% (24 cases) did not present the disorder while of the vestibular
symptoms; unsteadiness and staggering both evidenced in 65/78 subjects (83.33%) at the beginning of the therapy, disappeared in the
43.08%.
In conclusion dual action of the treatment showed improvement of tinnitus and dizziness symptoms, which was confirmed
either by symptoms’ reduction and by THI and DHI score.
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the blood supply of 10 cranial nerves, all ascending
and descending tracts, parts of the cortical hemi-
spheres, the cerebellum, the brainstem reticular for-
mation, and the end-organs of hearing and balance
(cochlea, semicircular canals, otolith system and
vestibular sensory cells)(8,9). Therefore an insuffi-
cient blood supply, causes alteration and/or death of
these structures like hair cells causing a discontinu-
ous aberrant neuronal activity characterized by
unsteadiness and tinnitus due to peripheral and/or
central dysfunction. For this reason it would be use-
ful to act at both central and peripheral, especially
in elderly where the atherosclerosis of the supra-
aortic trunks with insufficient collateral circulation
and compression of vertebral arteries by cervical
spondylosis with the subclavian steal syndrome are
common clinical reports(3,10).  
The aim of this study was to focus the
audiovestibular disorders, on patients suffering
from tinnitus and dizziness, in absence of organic
central or systemic diseases in time, treating them
with fixed combination - CINNARIZINE AND
DIMENHYDRINATE two times a day for 60 con-
secutive days.
Materials and methods 
The study was conducted by Department of
Audiology of Palermo University on 78 consecu-
tive subjects, 43 males and 35 females, ranging
from 43 to 87 years of age suffering from dizziness
and/or tinnitus with exclusion of central nervous
system diseases.
As for the analysis of data collected, the fol-
lowing parameters were considered: age, sex,
vestibular symptoms (unsteadiness, staggering, ten-
dency to fall, swaying, vertigo due to change of
position, bowing, walking, eye movements),
headache, tinnitus, impaired hearing, aural fullness.
Patients evaluated their vertigo symptoms and/or
tinnitus intensities using a graded 3- point visual
analog scale ranging from 1 (no symptoms) to 3
(strong symptoms).
The audio/vestibular system was studied
through liminar audiometry (considering the fre-
quencies 0.5-1-2-4 kHz) and clinical vestibular
examination tests (bed side examination).
To value the perceived severity of dizziness
and tinnitus and its impact of life and the therapy
efficacy, the subjects were invited to compile
Dizziness Handicap Inventory (DHI) and Tinnitus
Handicap Inventory (THI). These tool are a 25-item
survey that are composed of three subscales: a
functional subscale (12 items), an emotional sub-
scale (8 items) and a somatic response subscale (5
items) which address role and physical functioning,
psychological distress, desperation and loss of con-
trol, respectively. Each item has 3 potential answers
with “yes” assigned 4 points, “sometimes” 2 points,
and “no” 0 points. This leads to a total score rang-
ing from 0 indicating no tinnitus/dizziness handicap
and 100 the worst patients’ annoyance.
Overall patients were subjected to an entry
examination (first appointment, before start of treat-
ment), an intermediate examination (second visit,
after fifteen + 3 days), and a final examination at
the end of treatment (60 + 5 days). On the occasion
of each visit, patients underwent an efficacy evalua-
tion that was based primarily on the patient’s
assessments of the intensities of their audio-
vestibular symptoms. In addition, it was investigat-
ed the audiometric threshold and the bed side
examination. 
For the statistical analysis “Student’s t-test”,
linear regression (r value) and/or ANOVA test were
used, following usual conditions of application.
Significance was set at 0.05.
Results
Of the 78 patients, 43 (55.19%) males and 35
(44.87%) females, aged between 43 and 87 with a
mean age of 65.30. In 85.9% (67 cases) the subjects
underwent ENT examination for vestibular disor-
ders; of them in 76.12% corresponding to 51 cases
this disorder was associated to tinnitus while in 16
patients the annoyance was isolated. In the other 11
cases (14.1%) the only disorder resulted the tinni-
tus. Table 1 shows the distribution of the vestibular
symptoms reported by cohort; in particular at the
moment of the first examination, unsteadiness,
staggering and bowing evidenced the higher per-
centage values of strong intensity (respectively of
50%, 50%, 51.28%).
The study of the mean and median vertigo
scores (figure 1) also confirm as stated above while
the tendency to fall, vertigo due to change position,
head movements, walking and swaying presented
lower scores. Through the DHI questionnaire the
patients, were divided into five severity levels.
With a percentage of 52.56% (41 cases) cata-
strophic level was the main represented, followed
by the severe level with 16.66% corresponding to
13 subjects. 
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The 79.48% of cases corresponding to 62/78
suffered from tinnitus at first examination; of them
36 (58.06%) had a level 3 of tinnitus. The tinnitus
symptom accompanied hearing loss in the 90.32%
of cases (56 patients). The audiological assessment
evidenced a slight hearing loss for the frequencies
0,5, 1 and 2 KHz while a middle hearing loss for 4
kHz. With a percentage of 29,49% (23 cases) cata-
Audiovestibular symptoms Subjective scale range
Examination (days) Statistical analysis (r)
T 0 T 15 + 3 T 60 + 5
0.99
UNSTEADINESS
1 16.66% 37.18% 52.56%
2 33.33% 34.62% 39.74%
3 50% 28.20% 7.69%
STAGGERING
1 16.66% 37.18% 52.56%
0.992 33.33% 34.62% 39.74%
3 50% 28.20% 7.69%
TENDENCY
TO FALL
1 52.57% 66.66% 79.48%
0.982 15.38% 19.23% 14.11%
3 32.05% 14.11% 6.41%
SWAYING
1 37.18% 58.97% 73.08%
0.952 34.62% 30.77% 19.23%
3 28.20% 10.26% 7.69%
VERTIGO DUE
TO CHANGE OF
POSITION
1 50% 70.51% 80.77%
0.952 14.11% 16.66% 16.66%
3 35.89% 12.82% 2.56%
BOWING
1 33.33% 53.84% 74.36%
0.992 15.38% 17.95% 19.23%
3 51.28% 29.49% 6.41%
VERTIGO DUE
TO WALKING
1 41.03% 58.97% 76.92%
0.992 26.92% 20.51% 11.54%
3 32.05% 20.51% 11.54%
VERTIGO DUE
TO HEAD MOVEMENTS
1 42.31% 69.23% 75.64%
0.952 20.51% 10.26% 17.95%
3 37.18% 20.51% 6.41%
TINNITUS
1 20.51% 41.03% 51.28%
0.992 33.33% 21.79% 37.18%
3 46.15% 41.03% 11.54%
FULLNESS
1 53.84% 80.77% 94.87%
0.962 21.79% 11.54% 5.13%
3 24.35% 7.6% -
Table 1: distribution of the audiovestibular symptoms during time and, correlation index (r) of the mean values.
Fig. 1a- 1b: Study and progression of the mean (a) and median (b) vertigo scores.
strophic level was the main represented at THI
results, followed by the severe level with 28,20%
corresponding to 22 subjects.
Overall patients were treated with fixed com-
bination - CINNARIZINE AND DIMENHYDRI-
NATE two times a day for two months and, were
examined two times: during the treatment (15 days
+ 3) and at the end of the protocol therapy.
From the data it was evidenced a statistical
significant improvement either of the tinnitus and
of the vestibular symptoms. In fact at the final
examination, of the patients suffered from tinnitus,
the 38.71% (24/62 cases) did not present the disor-
der, while the 14.51% (9/62) did not observed any
improvement (t = 3.72; p<0.001). These data are
confirmed by THI results; with mean values of
56.41, 52.49 and 40.05 respectively at first exami-
nation, during the treatment and at the end of the
therapy, only the 1.28% of the subjects presented a
5 grade of disability after treatment while in
26.51% the disorder disappeared (t = 3.57;
p<0.001) (figure 2a).
Of the vestibular symptoms, unsteadiness and
staggering both evidenced in 65/78 subjects
(83.33%) at the beginning of the therapy, disap-
peared in the 43.08% corresponding to 28 cases,
improved in 47.69% while remained unchanged in
9.23%. Bowing symptom presented in 52/78 cases
(66.66%) disappeared in 61.53%, improved in
28.54% and unchanged in 9.61%. DHI score mean
values resulted respectively of 65.25, 57.77 and
45.87 at first appointment, at intermediate examina-
tion and at the end of treatment (t = 4.12; p<0.001)
(figure 2b).
Finally even if it was observed a slight
improvement of the hearing threshold level
between the first and the final examination, espe-
cially for the 4 KHz (first examination - 54 dB HL;
after treatment - 49.49 dB HL), the statistical study
of the means did not resulted significant (p>0.01).
Discussion
Tinnitus and dizziness are a multifactorial
symptoms provoking an important decrease in the
quality of life(11,12); the etiology is not yet fully
understood because there are different local and/or
systemic triggers (cardiovascular, vertebrobasilar
insufficiency, metabolic, etc.)(13,14). The epidemio-
logical data have generally supported a strong asso-
ciation between tinnitus and dizziness especially in
the higher ages, probably due to an higher preva-
lence of associated disorders that act as predispos-
ing conditions(15,16,17).
When present, the sensorineural hearing loss is
usually limited to the high frequencies (89.74% of
cases in our study), probably lead to tonotopic map
of acustic nerve that plays a significant role in the
pitch of tinnitus. The fact that the pitch of tinnitus
corresponds to the injured area of the nerve in its
tonotopic map was also referred by Savastano,
Satar et al.(18,19,20). 
According to literature, vestibular symptoms
in patients with impaired vascular are mainly char-
acterized by a sense of instability, 83.4% (65/79
patients) of cases, rather than paroxysmal vertigo,
which makes them insecure.
In this study in fact, were included patients
suffering from vascular both peripheral and central
referring a clear impairment of daily activities and a
higher psychological distress that has been shown
by scores of DHI and THI. 
Because the cohort would be mainly affected
by alterations in the microcirculation with impair-
ment in both central and peripheral region, the two
active components of the fixed combination have
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Fig. 2a- 2b: a) THI score – Cohort distribution; b) DHI
score - Cohort distribution.
distinct pharmacological properties that comple-
ment one another synergistically; while cinnarizine
acts predominantly on the peripheral vestibular
labyrinth by affecting local calcium ion flux,
dimenhydrinate is primarily effective on central
structures, mainly the vestibular nuclei and adjacent
vegetative centres in the brainstem(21).
As demonstrated by Otto et al. the calcium
antagonist cinnarizine, acts by enhancing circula-
tion in the peripheral vestibular organ and in com-
promised intra and extracranial areas; the action of
cinnarizine is reinforced by dimenhydrinate
because inhibits the spreading of impulses at the
medullar vestibular nuclei(22,23,24). In particular, in
Otto’s study were evaluated three groups of patients
for a total of 37, of which 11 were treated with the
fixed combination, 13 with betahistine and 13 with
placebo. The results(25) showed a statistically signifi-
cant improvement in the first group of patients just
after one week of treatment respect to those treated
with betahistine and placebo(8).
Also in our cohort it was evidenced, as reported
by patients’ responses at DHI and THI, a slight
improvement of dizziness and tinnitus after two
weeks of treatment but it resulted significant only
after two months of treatment. The physiopathologi-
cal correlate of these results, in patients suffering
from tinnitus and dizziness in presence of microcir-
culation disorders, can be found in the particular
blood supply end of the cochlea.
Therefore the prompt therapy targeted at ante-
rior labyrinth artery reperfusion should prevent hair
cells’ death and the ‘onset of acute tinnitus, while a
long term therapy leads to recovered labyrinthic
function and it’s maintenance.
Conclusions
The present results, according to literature
data, have proven that the fixed combination of cin-
narizine and dimenhydrinate is an effective thera-
peutic option in treating vertigo and tinnitus due to
vertebrobasilar insufficiency.
Dual action of the treatment showed improve-
ment of tinnitus and dizziness symptoms, which
was confirmed either by symptoms’ reduction
(38.71% and 43.08% respectively for tinnitus and
dizziness suffered were cured) and by the THI and
DHI score at final examination (p<0.001).
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